Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0312
A Phase II Study of IV Gemcitabine and Oral Capecitabine in Patients with Advanced Renal Cell Cancer
Research Committee(s)
Genitourinary Cancer
Activated
12-01-2004
Closed
08-15-2005
Closed
Phase
Accrual
33%
SWOG Clinical Trial Number
S0344
A Phase II Surgical Trial of Intralesional Resection of Low-Grade Intracompartmental Chondrosarcoma of Bone
Research Committee(s)
Sarcoma
Activated
12-01-2004
Closed
01-15-2007
Closed
Phase
Accrual
40%
Published
SWOG Clinical Trial Number
S0232
Double-Blinded Placebo Controlled Phase III Trial Comparing Dexamethasone (DEX) to the Combination of DEX + CC-5013 in Patients with Previously Untreated Multiple Myeloma who are Not Immediately Undergoing Autologous Stem Cell Transplant
Research Committee(s)
Myeloma
Activated
11-01-2004
Closed
05-11-2007
Closed
Phase
Accrual
8%
SWOG Clinical Trial Number
S0300
Randomized Placebo-Controlled Biomarker Modulation Trial Using Celecoxib in Premenopausal Women at High Risk for Breast Cancer
Research Committee(s)
Breast Cancer
Activated
11-01-2004
Closed
05-13-2008
Closed
Phase
Accrual
5%
SWOG Clinical Trial Number
S0224
Phase II Study of Weekly Docetaxel in Patients with Advanced Epidermoid Carcinoma of the Penis
Research Committee(s)
Genitourinary Cancer
Activated
10-15-2004
Closed
11-15-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0415
Cetuximab as a Second Line Therapy in Patients with Metastatic Esophageal Cancer - Phase II
Activated
10-15-2004
Closed
01-01-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0420
Phase II Evaluation of BAY 43-9006 (NSC-724772) in Patients with Recurrent or Metastatic Head and Neck Cancer
Research Committee(s)
Head and Neck Cancer
Activated
10-01-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0341
Phase II Trial of OSI-774 (NSC-718781) in Patients with Advanced Non-Small Cell Lung Cancer and a Performance Status of 2
Research Committee(s)
Lung Cancer
Activated
09-15-2004
Closed
10-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0356
Oxaliplatin Plus Protracted Infusion 5-Fluorouracil and Radiation for Potentially Curable Esophageal Cancer: A Phase II Trial with Molecular Correlates
Research Committee(s)
Gastrointestinal Cancer
Activated
09-15-2004
Closed
08-01-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0432
Phase II Studies of Two Different Schedules and Two Different Doses of the Farnesyl Transferase Inhibitor R115777 (Tipifarnib, Zarnestra�, NSC-702818)for Previously Untreated Acute Myeloid Leukemia (AML) in Patients of Age 70 or Older.
Research Committee(s)
Leukemia
Activated
09-15-2004
Closed
02-21-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0412
A Phase II Study of the RAF-Kinase Inhibitor BAY 43-9006 (NSC-724772, IND-69,896) in Combination with Interferon Alpha 2b in Patients wtih Advanced Renal Cancer
Research Committee(s)
Genitourinary Cancer
Activated
09-01-2004
Closed
05-15-2005
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
S0229
A Randomized Trial Assessing the Effects of Exercise on Patients with Locally Advanced Lung Cancer Undergoing Curative Intent Combined Modality Therapy
Research Committee(s)
Lung Cancer
Activated
09-01-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0325
A Phase IIb Study of Molecular Responses to Imatinib, at Standard or Increased Doses, or Dasatinib (BMS-354825) (NSC-732517) for Previously Untreated Patients With Chronic Myelogenous Leukemia (CML) in Chronic Phase.
Research Committee(s)
Leukemia
Activated
08-15-2004
Closed
02-28-2009
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0304
A Phase II Feasibility Translational Research Trial of Induction Chemotherapy Followed by Concomitant Chemoradiation in Patients with Clinical T3-T4 Rectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
08-01-2004
Closed
02-01-2006
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
S0316
Barriers to Accrual to Clinical Trials in Older (>= 65 Years) Cancer Patients
Status Notes
Activated
08-01-2004
Closed
06-15-2008
Closed
Phase
Published
SWOG Clinical Trial Number
S0000B
Prevention of Cataract and Age-Related Macular Degeneration with Vitamin E and Selenium - SELECT Eye Endpoints (SEE)
Research Committee(s)
Other
Activated
07-01-2004
Closed
07-31-2015
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0342
Phase II Selection Design Trial of Concurrent Chemotherapy + Cetuximab vs. Chemotherapy Followed by Cetuximab in Advanced Non-Small Cell Lung Cancer (NSCLC)
Research Committee(s)
Lung Cancer
Activated
07-01-2004
Closed
08-01-2005
Closed
Phase
Accrual
39%
Published
SWOG Clinical Trial Number
S0338
Phase II Trial of Imatinib Mesylate (Gleevec) (NSC-716051) In Combination With Capecitabine (Xeloda) (NSC-712807) In Metastatic Breast Cancer
Research Committee(s)
Breast Cancer
Activated
06-15-2004
Closed
12-15-2005
Closed
Phase
Accrual
15%
SWOG Clinical Trial Number
S0400
A Phase II Study of Depsipeptide (NSC-630176) in Patients with Advanced Transitional Cell Carcinoma of the Urinary Tract Who Have Progressed After Receiving One Prior Chemotherapy Regimen for Advanced Disease
Research Committee(s)
Genitourinary Cancer
Activated
06-15-2004
Closed
04-15-2006
Closed
Phase
Accrual
94%
Published
SWOG Clinical Trial Number
S0000C
Prevention of Lung Function Decline with Vitamin E and Selenium - Respiratory Ancillary Study (RAS) to SELECT
Research Committee(s)
Other
Activated
06-04-2004
Closed
05-01-2007